122 related articles for article (PubMed ID: 38234119)
1. Ubiquitination, SUMOylation, and NEDDylation related genes serve as prognostic and therapeutic biomarkers for oral squamous cell carcinoma.
Deng SZ; Wu X; Kong L; Cheng B; Dai L
J Oral Pathol Med; 2024 Feb; 53(2):114-123. PubMed ID: 38234119
[TBL] [Abstract][Full Text] [Related]
2. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
3. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
[TBL] [Abstract][Full Text] [Related]
4. Identification of an endoplasmic reticulum stress-related prognostic risk model with excellent prognostic and clinical value in oral squamous cell carcinoma.
Cheng M; Fan X; He M; Dai X; Liu X; Hong J; Zhang L; Liao L
Aging (Albany NY); 2023 Aug; 15(19):10010-10030. PubMed ID: 37647077
[TBL] [Abstract][Full Text] [Related]
5. Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma.
Xu Z; Li X; Pan L; Tan R; Ji P; Tang H
J Oral Pathol Med; 2022 Apr; 51(4):358-368. PubMed ID: 35100473
[TBL] [Abstract][Full Text] [Related]
6. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
7. [MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
Zhao G; Li CX; Guo C; Zhu H
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Dec; 38(6):622-627. PubMed ID: 33377337
[TBL] [Abstract][Full Text] [Related]
8. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H
BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Zhang YY; Mao MH; Han ZX
Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
[TBL] [Abstract][Full Text] [Related]
10. Prognostic model based on telomere-related genes predicts the risk of oral squamous cell carcinoma.
Yue K; Yao X
BMC Oral Health; 2023 Jul; 23(1):484. PubMed ID: 37452322
[TBL] [Abstract][Full Text] [Related]
11. Prognostic model revealing pyroptosis-related signatures in oral squamous cell carcinoma based on bioinformatics analysis.
Qi L; Tang Z
Sci Rep; 2024 Mar; 14(1):6149. PubMed ID: 38480853
[TBL] [Abstract][Full Text] [Related]
12. Identification of Nine M6A-Related Long Noncoding RNAs as Prognostic Signatures Associated with Oxidative Stress in Oral Cancer Based on Data from The Cancer Genome Atlas.
Shan L; Lu Y; Song Y; Zhu X; Xiang CC; Zuo ED; Cheng X
Oxid Med Cell Longev; 2022; 2022():9529814. PubMed ID: 35910847
[TBL] [Abstract][Full Text] [Related]
13. A prognostic Risk Score model for oral squamous cell carcinoma constructed by 6 glycolysis-immune-related genes.
Liu Y; Wang T; Li R
BMC Oral Health; 2022 Aug; 22(1):324. PubMed ID: 35922788
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
[TBL] [Abstract][Full Text] [Related]
15. A novel and independent survival prognostic model for OSCC: the functions and prognostic values of RNA-binding proteins.
Wang S; Liu S; Zhu Y; Zhang B; Yang Y; Li L; Sun Y; Zhang L; Fan L; Hu X; Huang C
Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):397-409. PubMed ID: 37656222
[TBL] [Abstract][Full Text] [Related]
16. Implications of Human Antimicrobial Peptide Defensin Beta-1 in Clinical Oral Squamous Cell Carcinoma Patients via an Integrated Bioinformatics Approach.
Li S; Li H; Xu Y; Ning W; Hu S; Wei S; Song H; Sun J; Ziebolz D; Schmalz G; Hu X; Liu M
Comput Math Methods Med; 2022; 2022():2203615. PubMed ID: 35222682
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma.
Zhou X; Jin W; Chen Y; Zhu L; Mo A; Xie Q
Pharmacogenet Genomics; 2022 Jun; 32(4):125-137. PubMed ID: 34954767
[TBL] [Abstract][Full Text] [Related]
18. A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden.
Wu F; Du Y; Hou X; Cheng W
BMC Oral Health; 2022 Apr; 22(1):152. PubMed ID: 35488327
[TBL] [Abstract][Full Text] [Related]
19. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation.
Zhang G; Zhao X; Liu W
Cancer Biol Ther; 2022 Dec; 23(1):243-253. PubMed ID: 35316145
[TBL] [Abstract][Full Text] [Related]
20. A novel T-cell proliferation-associated gene predicts prognosis and reveals immune infiltration in patients with oral squamous cell carcinoma.
Cui Y; Cheng Y; Huang W; Liu J; Zhang X; Bu M; Li X
Arch Oral Biol; 2023 Aug; 152():105719. PubMed ID: 37178584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
